WallStreetZenWallStreetZen

NASDAQ: PROF
Profound Medical Corp Stock Forecast, Predictions & Price Target

Analyst price target for PROF

Based on 2 analysts offering 12 month price targets for Profound Medical Corp.
Min Forecast
$9.00+8.7%
Avg Forecast
$9.90+19.57%
Max Forecast
$10.80+30.43%

Should I buy or sell PROF stock?

Based on 2 analysts offering ratings for Profound Medical Corp.
Buy
Strong Buy
1 analysts 50%
Buy
0 analysts 0%
Hold
1 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their PROF stock forecasts and price targets.

PROF stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-11
lockedlocked$00.00+00.00%2024-03-08

1 of 1

Forecast return on equity

Is PROF forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
37.5%

Forecast return on assets

Is PROF forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

PROF revenue forecast

What is PROF's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$11.0M+103.68%
Avg 2 year Forecast
$29.9M+451.47%
Avg 3 year Forecast
$51.7M+855.37%
PROF's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

PROF revenue growth forecast

How is PROF forecast to perform vs Medical Devices companies and vs the US market?
Company
113.07%
Industry
8.09%
Market
10.52%
PROF's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
PROF's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

PROF vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
PROF$8.28$9.90+19.57%Buy
CLPT$6.72$9.00+33.93%Strong Buy
QIPT$4.34$10.00+130.41%Buy
INGN$7.97$7.00-12.12%Strong Sell
SMLR$28.55N/AN/A

Profound Medical Stock Forecast FAQ

Is Profound Medical Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: PROF) stock is to Buy PROF stock.

Out of 2 analysts, 1 (50%) are recommending PROF as a Strong Buy, 0 (0%) are recommending PROF as a Buy, 1 (50%) are recommending PROF as a Hold, 0 (0%) are recommending PROF as a Sell, and 0 (0%) are recommending PROF as a Strong Sell.

If you're new to stock investing, here's how to buy Profound Medical stock.

What is PROF's revenue growth forecast for 2024-2026?

(NASDAQ: PROF) Profound Medical's forecast annual revenue growth rate of 113.07% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.09%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.52%.

Profound Medical's revenue in 2024 is $5,293,382.On average, 4 Wall Street analysts forecast PROF's revenue for 2024 to be $235,610,479, with the lowest PROF revenue forecast at $224,390,933, and the highest PROF revenue forecast at $252,172,667. On average, 4 Wall Street analysts forecast PROF's revenue for 2025 to be $637,911,365, with the lowest PROF revenue forecast at $373,984,888, and the highest PROF revenue forecast at $961,675,425.

In 2026, PROF is forecast to generate $1,105,114,657 in revenue, with the lowest revenue forecast at $564,182,916 and the highest revenue forecast at $1,844,279,760.

What is PROF's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: PROF) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of N/A.

What is PROF's Price Target?

According to 2 Wall Street analysts that have issued a 1 year PROF price target, the average PROF price target is $9.90, with the highest PROF stock price forecast at $10.80 and the lowest PROF stock price forecast at $9.00.

On average, Wall Street analysts predict that Profound Medical's share price could reach $9.90 by Mar 11, 2025. The average Profound Medical stock price prediction forecasts a potential upside of 19.57% from the current PROF share price of $8.28.

What is PROF's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: PROF) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.